Past, present, and future of CRISPR genome editing technologies
Cell · 2024-02 · 187 (5) · 1076-1100
DOI: 10.1016/j.cell.2024.01.042 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cell, 2024-02. Verfasst von Martin Pacesa und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Protein Design and Immunoengineering, École Polytechnique Fédérale de Lausanne and Swiss Institute of Bioinformatics, Station 19, CH-10…. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Gene Editing. Die Arbeit wurde bisher 642-mal zitiert (Crossref) und nennt 344 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swiss National Science Foundation, European Research Council.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Laboratory of Protein Design and Immunoengineering, École Polytechnique Fédérale de Lausanne and Swiss Institute of Bioinformatics, Station 19, CH-1015 Lausanne, Switzerland.
- Department of Biochemistry, University of Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland.
- Department of Biochemistry, University of Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland. Electronic address: jinek@bioc.uzh.ch.
Förderung
- Swiss National Science Foundation
- European Research Council
Zitieren
APA
Pacesa, M., Pelea, O., & Jinek, M. (2024). Past, present, and future of CRISPR genome editing technologies. Cell, 187(5), 1076-1100. https://doi.org/10.1016/j.cell.2024.01.042
Vancouver
Pacesa M, Pelea O, Jinek M. Past, present, and future of CRISPR genome editing technologies. Cell. 2024;187(5):1076-1100. doi:10.1016/j.cell.2024.01.042
BibTeX
@article{Pacesa2024,
author = {Pacesa, Martin and Pelea, Oana and Jinek, Martin},
title = {Past, present, and future of CRISPR genome editing technologies},
journal = {Cell},
year = {2024},
volume = {187},
number = {5},
pages = {1076--1100},
doi = {10.1016/j.cell.2024.01.042}
}
EUVIMED